These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9616229

  • 1. Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
    Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC, Whiteside TL.
    J Clin Invest; 1998 Jun 01; 101(11):2579-88. PubMed ID: 9616229
    [Abstract] [Full Text] [Related]

  • 2. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
    Taylor DD, Gerçel-Taylor C, Lyons KS, Stanson J, Whiteside TL.
    Clin Cancer Res; 2003 Nov 01; 9(14):5113-9. PubMed ID: 14613988
    [Abstract] [Full Text] [Related]

  • 3. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL.
    Clin Cancer Res; 2002 Oct 01; 8(10):3137-45. PubMed ID: 12374681
    [Abstract] [Full Text] [Related]

  • 4. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 5. The role of apoptosis in normal ontogenesis and solid human neoplasms.
    Kaiser HE, Bodey B.
    In Vivo; 2000 Oct 15; 14(6):789-803. PubMed ID: 11204498
    [Abstract] [Full Text] [Related]

  • 6. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL.
    Clin Cancer Res; 2001 Mar 15; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [Abstract] [Full Text] [Related]

  • 7. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL.
    Clin Cancer Res; 2002 Aug 15; 8(8):2553-62. PubMed ID: 12171883
    [Abstract] [Full Text] [Related]

  • 8. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL.
    Syed V, Ho SM.
    Oncogene; 2003 Oct 09; 22(44):6883-90. PubMed ID: 14534535
    [Abstract] [Full Text] [Related]

  • 9. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 09; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 10. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
    Satchell AC, Barnetson RS, Halliday GM.
    Br J Dermatol; 2004 Jul 09; 151(1):42-9. PubMed ID: 15270871
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 12. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb 15; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 13. Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
    Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside TL.
    Clin Cancer Res; 1996 Jan 15; 2(1):161-73. PubMed ID: 9816103
    [Abstract] [Full Text] [Related]

  • 14. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L, Radrizzani M, Accornero P, Squarcina P, Chiodoni C, Mazzocchi A, Castelli C, Tarsini P, Viggiano V, Belli F, Colombo MP, Parmiani G.
    J Immunol; 1998 Aug 01; 161(3):1220-30. PubMed ID: 9686582
    [Abstract] [Full Text] [Related]

  • 15. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
    Li B, Bassiri H, Rossman MD, Kramer P, Eyuboglu AF, Torres M, Sada E, Imir T, Carding SR.
    J Immunol; 1998 Aug 01; 161(3):1558-67. PubMed ID: 9686624
    [Abstract] [Full Text] [Related]

  • 16. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X, Hazarika P, Zhang C, Talpur R, Duvic M.
    Clin Cancer Res; 2001 Sep 01; 7(9):2682-92. PubMed ID: 11555580
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis.
    Fujii M, Hayashi K, Niki M, Chiba N, Meguro K, Endo K, Kameoka J, Ito S, Abe K, Watanabe T, Satake M.
    Oncogene; 1998 Oct 08; 17(14):1813-20. PubMed ID: 9778047
    [Abstract] [Full Text] [Related]

  • 18. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 08; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 19. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 20. Fas/Fas ligand system and apoptosis induction in testicular carcinoma.
    Schmelz HU, Abend M, Kraft K, Hauck EW, Weidner W, Van Beuningen D, Sparwasser C.
    Cancer; 2002 Jul 01; 95(1):73-81. PubMed ID: 12115319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.